查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1778495

全球凤梨蛋白酶市场：成长、规模及趋势分析 - 按形态与应用 - 区域展望、竞争策略及2034年细分市场预测

Bromelain Market Size- By Form, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

根据《全球凤梨蛋白酶市场：成长、规模和趋势分析—按形式、按应用—区域展望、竞争策略和 2034 年细分预测》报告，全球凤梨蛋白酶市场规模预计到 2034 年将达到 5,624 万美元，复合年增长率为 6.94%。

凤梨蛋白酶是一种天然酶，存在于凤梨茎和果实中。它有助于分解蛋白质，有利于肉类嫩化、消化和消炎。由于其药用和功能特性，凤梨蛋白酶广泛应用于补充剂、製药、化妆品以及食品和饮料行业。

限制因素：儘管凤梨蛋白酶的用途日益广泛，但其市场仍面临许多挑战。凤梨蛋白酶提取自菠萝，而菠萝受季节和环境因素的影响，导致供应和价格不稳定。此外，凤梨蛋白酶的萃取和精製过程耗时长、成本高，限制了中小企业的生产扩充性。

调查范围

报告指标详情

市场规模：2021-2034年

基准年：2024年

预测期：2025-2034年

目标细分市场：按类型和用途

涵盖地区：北美、拉丁美洲、亚太地区、欧洲、中东和非洲

目标公司：Advanced Enzymes、Biozyme Laboratories、Creative Enzymes、Digestive Enzymes International、Enzybel International、Enzyme Development、鸿茂生化、Integrative Therapeutics、Mountain Fresh、南宁东海生物科技、南宁庞博生物工程

全球菠萝蛋白酶市场细分：

依形式：全球凤梨蛋白酶市场依形式分为粉末、液体和其他。

依应用：全球凤梨蛋白酶市场根据应用分为食品和饮料、膳食补充剂、药品、化妆品和个人护理等。

按地区：研究还包括来自北美、拉丁美洲、亚太地区、欧洲以及中东和非洲的数据。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场动态

  • 驱动因素、限制因素、机会与挑战分析

第五章 市场变数与展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 热图分析

第六章 竞争态势

  • 全球凤梨蛋白酶市场：製造地分布、销售区域与产品类型
  • 全球凤梨蛋白酶市场的併购、合作伙伴关係、产品发布和合作

7. 全球凤梨蛋白酶市场（按形式划分，百万美元），2021-2034 年

  • 粉末
  • 液体
  • 其他的

8. 全球凤梨蛋白酶市场，按应用划分（百万美元），2021 年至 2034 年

  • 食品/饮料
  • 营养补充品
  • 製药
  • 化妆品和个人护理
  • 其他的

9. 2021-2034 年全球凤梨蛋白酶市场（百万美元）

  • 全球菠萝蛋白酶市场规模和市场占有率

第 10 章。 2021 年至 2034 年全球凤梨蛋白酶市场（按地区划分，单位：百万美元）

  • 亚太地区
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他的
  • 欧洲
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 英国
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯王国
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亚
    • 其他的
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美国
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他的

第十一章：公司简介

  • Advanced Enzymes
  • Biozyme Laboratories
  • Creative Enzymes
  • Digestive Enzymes International
  • Enzyme Development
  • Hong Mao Biochemicals
  • Integrative Therapeutics
  • Mountain Fresh
  • Nanning Doing-Higher Bio-Tech
  • 其他的

第十二章 结论

第十三章简称表

第 14 章参考链接

简介目录
Product Code: FOOD2576

Bromelain Market Introduction and Overview

According to SPER Market Research, 'Global Bromelain Market Size- By Form, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034' the Global Bromelain Market is estimated to reach USD 56.24 million by 2034 with a CAGR of 6.94%.

Bromelain is a naturally occurring enzyme found in pineapple stems and fruits. It aids in protein breakdown, making it effective for purposes such as meat tenderisation, digestive support, and inflammation reduction. Because of its medicinal and functional properties, bromelain is widely utilised in supplements, pharmaceuticals, cosmetic products, and the food and beverage industry.

Restraints: Despite its growing use, the bromelain market faces several challenges. The primary issue is that bromelain is sourced from pineapples, which are affected by seasonal and environmental factors, leading to unstable supply and pricing. The process of extracting and purifying bromelain is also time-consuming and expensive, limiting production scalability for smaller companies.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Form, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Advanced Enzymes, Biozyme Laboratories, Creative Enzymes, Digestive Enzymes International, Enzybel International, Enzyme Development, Hong Mao Biochemicals, Integrative Therapeutics, Mountain Fresh, Nanning Doing-Higher Bio-Tech, Nanning Pangbo Biological Engineering.

Global Bromelain Market Segmentation:

By Form: Based on the Form, Global Bromelain Market is segmented as; Powder, Liquid, Others

By Application: Based on the Application, Global Bromelain Market is segmented as; Food & beverages, Nutraceuticals, Pharmaceuticals, Cosmetics & personal care, Others

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bromelain Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bromelain Market

7. Global Bromelain Market, By Form (USD Million) 2021-2034

  • 7.1. Powder
  • 7.2. Liquid
  • 7.3. Others

8. Global Bromelain Market, By Application (USD Million) 2021-2034

  • 8.1. Food & beverages
  • 8.2. Nutraceuticals
  • 8.3. Pharmaceuticals
  • 8.4. Cosmetics & personal care
  • 8.5. Others

9. Global Bromelain Market, (USD Million) 2021-2034

  • 9.1. Global Bromelain Market Size and Market Share

10. Global Bromelain Market, By Region, (USD Million) 2021-2034

  • 10.1. Asia-Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
    • 10.1.6. Rest of Asia-Pacific
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia
    • 10.3.2. United Arab Emirates
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5. Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America

11. Company Profile

  • 11.1. Advanced Enzymes
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Biozyme Laboratories
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Creative Enzymes
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. Digestive Enzymes International
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Enzyme Development
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Hong Mao Biochemicals
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Integrative Therapeutics
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Mountain Fresh
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Nanning Doing-Higher Bio-Tech
    • 11.9.1. Company details
    • 11.9.2. Financial outlook
    • 11.9.3. Product summary
    • 11.9.4. Recent developments
  • 11.10. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links